Leadership News
Meet four MMRF cancer fighters
Our team members bring different strengths, and are united by their passion,
determination, and commitment to cure cancer now.
Thomas Conheeney,
MMRF Board Member
Steven Shak, M.D.,
MMRF Board Member
The MMRF is pleased to announce that Thomas
The MMRF eagerly welcomes Steven Shak, M.D., to our
Conheeney, retired president of SAC Capital, has
Board of Directors. Steve is a co-founder of Genomic
joined our Board of Directors. “Tom’s commitment
Health, Inc., serving as Chief Scientific Officer since
to our work and his deep experience in the areas of
2012 and Chief Medical Officer from 2000-2013.
capital markets and finance will be invaluable to the
Under his leadership, Genomic Health creates innovative
Foundation and our Board,” said Walter M. Capone,
molecular diagnostic methods and has maintained an
Chief Executive Officer and President of the MMRF.
80% product development success rate.
Tom was appointed President of SAC Capital in
Steve served for 14 years in various roles in Discovery
July 2008. He joined SAC in October 1999 as Chief
Research and Medical Affairs at Genentech, Inc., a
Operating Officer. Prior to joining SAC, Tom was
biotechnology company dedicated to using human
President of Investment Management Services, Inc.
genetic information to treat serious medical conditions.
(“IMS”) from 1996 to 1999. He joined Moore Capital/
“Steve has been on the leading edge of diagnostic and
IMS in 1993 and served as its Director of Trading
therapeutic advances in oncology for over two decades,
Operations and then Vice President until IMS split
augmenting the areas of greatest promise as we pursue
off from Moore in 1995. Prior to joining Moore
our mission for cures,” said Walter M. Capone, Chief
Capital/IMS, from 1986 to 1993, Tom held various
Executive Officer and President of the MMRF.
positions in the equity division at Goldman, Sachs
& Co., becoming Vice President in 1990. He retired
Before joining Genentech, Steve was an Assistant
from SAC December 2014, and now serves as a
Professor of Medicine and Pharmacology at New
Board Member for a number of organizations,
York University School of Medicine. He holds a B.A. in
including the King School in Stamford, CT where
chemistry from Amherst College and an M.D. from New
he is President of the Board.
York University School of Medicine, and did his postdoctoral work at University of California, San Francisco.
16
T HE MMRF.ORG